PLOD1 and aneuploidy: While it seems conceivable that LH supplementation could mitigate the age-related impairment of both androgen production and androgen follicular fluid levels [30], the age-related aneuploidy rate, which becomes increasingly more relevant in women above the age of 40 years [34], seems to be unavoidable regardless of the type or dose of the gonadotropin regimen used.